Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

Elena Ardini(Nerviano Medical Sciences), Arturo Galvani(Nerviano Medical Sciences)

Molecular Cancer Therapeutics

March 3, 2016

10.1158/1535-7163.mct-15-0758

Cited by 312

Related Papers

No related papers found

Powered by citation graph analysis